Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Knowing what to include in your retirement portfolio at 30 can set you up for success. Learn about essential assets and strategies.
20,742 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Curious about what the Agilent 2026 earnings call means for investors? This article breaks down the key takeaways, po...
If you manage rental property on your own, you might be leaving thousands on the table. This guide uncovers seven pla...
Two very different retail giants compete for investors' attention in 2026. This guide breaks down whether Abercrombie...
When a tech insider sells a large stake, investors weigh a range of signals. This guide breaks down what the move cou...
In 2026, investors face a classic showdown: a rapid-growth dermatology
Three social platforms are drawing fresh attention as growth meets reasonable prices. Here’s a practical, investor-fr...
A major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...
A sharp February pullback put Intel back in focus. This guide breaks down the drivers, the long-term thesis, and how ...
Tech ETFs offer fast access to the U.S. tech sector, but costs and portfolio makeup vary. This guide breaks down the ...
A fast-growing tech name in the AI space has dazzled investors, but a recent funding move underscored a crucial risk....